| Home : April 2011 : April 11, 2011 News : Heptares and Takeda Initiate Drug Discovery Collaboration Focused on GPCR Linked to CNS Disorders |
Heptares and Takeda Initiate Drug Discovery Collaboration Focused on GPCR Linked to CNS Disorders |
April 11, 2011
CAMBRIDGE, England, April 11, 2011 /PRNewswire/ --
- Deal Includes GBP4.5 Million Upfront Cash and Equity, Up to GBP60.5
Million in Future Milestone Payments, and Royalties on Product Sales
Heptares Therapeutics and Takeda Pharmaceutical Company today announced
the formation of a two-y
http://www.prnewswire.com/news-releases/heptares-and-takeda-initiate-drug-discovery-collaboration-focused-on-gpcr-linked-to-cns-disorders-119584024.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
